Argenx
ARGX
#456
Rank
$54.84 B
Marketcap
$877.62
Share price
-3.50%
Change (1 day)
56.36%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Annual Reports

Thumbnail Argenx
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2023

Annual Report 2023

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2020

Annual Report 2020

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2017

Annual Report 2017

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2016

Annual Report 2016

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2015

Annual Report 2015

Language: English

View Annual Report
Thumbnail Argenx
 Annual Report 2014

Annual Report 2014

Language: English

View Annual Report